NIVOPOSTOP trial data demonstrate a reduction in the risk of recurrence or death with adjuvant nivolumab combined with ...

Libtayo (cemiplimab) was cleared in 2018 for treating advanced CSCC in patients who are not candidates for curative surgery ...

Adjuvant Opdivo, cisplatin and radiotherapy improved DFS vs other treatment among those with locally advanced squamous cell ...

Adding nivolumab to adjuvant CRT improved DFS in patients with locally advanced head and neck squamous cell carcinoma at high risk of relapse.

"These long-term results continue to support [pembrolizumab's] use as a standard of care for patients at increased risk of ...

Researchers are also investigating the PD-1 immune checkpoint inhibitor as treatment before surgical and radiation treatment.

Study authors examined the diagnostic utility of radiologic imaging for patients with high-risk cutaneous squamous cell carcinoma.

A five-fraction, one-week schedule of adjuvant breast radiotherapy is as safe and effective as a standard three-week schedule ...

The international PORTEC-4a study offers strong evidence that molecular profiling can safely minimize radiotherapy in women ...

Discover a study that evaluated the effectiveness of hyperbaric oxygen therapy for radiation-induced dermatitis.

Among women with low-risk, early-stage cervical cancer, long-term survival outcomes were similar following simple, modified radical, or radical hysterectomy, according to an observational cohort study ...

More information: PORTEC-4a; an international randomised trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer, Radiotherapy and Oncology (2025).